Survival-associated metabolic genes in human papillomavirus-positive head and neck cancers MA Prusinkiewicz, SF Gameiro, F Ghasemi, MJ Dodge, PYF Zeng, ... Cancers 12 (1), 253, 2020 | 46 | 2020 |
Sex disparities in head & neck cancer driver genes: An analysis of the TCGA dataset N Mundi, F Ghasemi, PYF Zeng, SD Prokopec, K Patel, HAJ Kim, ... Oral oncology 104, 104614, 2020 | 26 | 2020 |
All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor … HAJ Kim, PYF Zeng, MH Shaikh, N Mundi, F Ghasemi, E Di Gravio, ... Oral Oncology 116, 105260, 2021 | 17 | 2021 |
F4/80+ Ly6Chigh macrophages lead to cell plasticity and cancer initiation in colitis AE Shin, Y Tesfagiorgis, F Larsen, M Derouet, PYF Zeng, HJ Good, ... Gastroenterology 164 (4), 593-609. e13, 2023 | 11 | 2023 |
Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis SF Gameiro, F Ghasemi, PYF Zeng, N Mundi, CJ Howlett, P Plantinga, ... Infectious Agents and Cancer 16, 1-10, 2021 | 11 | 2021 |
Cigarette smoke exposure attenuates the induction of antigen-specific IgA in the murine upper respiratory tract JJC McGrath, D Thayaparan, SP Cass, JP Mapletoft, PYF Zeng, ... Mucosal Immunology 14 (5), 1067-1076, 2021 | 10 | 2021 |
Analysis of the TCGA dataset reveals that subsites of laryngeal squamous cell carcinoma are molecularly distinct A Sorgini, HAJ Kim, PYF Zeng, MH Shaikh, N Mundi, F Ghasemi, ... Cancers 13 (1), 105, 2020 | 9 | 2020 |
Chromosome 3p loss in the progression and prognosis of head and neck cancer MH Shaikh, JW Barrett, MI Khan, HAJ Kim, PYF Zeng, JS Mymryk, ... Oral Oncology 109, 104944, 2020 | 9 | 2020 |
Comparative immunogenicity of the 2014–2015 Northern hemisphere trivalent IIV and LAIV against influenza A viruses in children JC Ang, B Wang, JJF Wang, PYF Zeng, F Krammer, BJ Ward, ML Russell, ... Vaccines 7 (3), 87, 2019 | 9 | 2019 |
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification PYF Zeng, MJ Cecchini, JW Barrett, M Shammas-Toma, L De Cecco, ... EBioMedicine 86, 2022 | 8 | 2022 |
Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotype N Pinto, KM Ruicci, MI Khan, MH Shaikh, YFP Zeng, J Yoo, K Fung, ... Journal of Otolaryngology-Head & Neck Surgery 51 (1), 7, 2022 | 8 | 2022 |
The HPV Induced Cancer Resource (THInCR): a suite of tools for investigating HPV-Dependent human carcinogenesis M Salnikov, SF Gameiro, PYF Zeng, JW Barrett, AC Nichols, JS Mymryk Msphere 7 (4), e00317-22, 2022 | 5 | 2022 |
Proteome and phosphoproteome signatures of recurrence for HPV+ head and neck squamous cell carcinoma T Kaneko, PYF Zeng, X Liu, R Abdo, JW Barrett, Q Zhang, AC Nichols, ... Communications medicine 2 (1), 95, 2022 | 4 | 2022 |
Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer HAJ Kim, PYF Zeng, A Sorgini, MH Shaikh, H Khan, D MacNeil, MI Khan, ... Head & neck 44 (5), 1124-1135, 2022 | 4 | 2022 |
3p arm loss and survival in head and neck cancer: an analysis of TCGA dataset HAJ Kim, MH Shaikh, M Lee, PYF Zeng, A Sorgini, T Akintola, X Deng, ... Cancers 13 (21), 5313, 2021 | 3 | 2021 |
Tumor cell extrinsic synaptogyrin 3 expression as a diagnostic and prognostic biomarker in head and neck cancer RM Murphy, J Tasoulas, A Porrello, MB Carper, YH Tsai, AR Coffey, ... Cancer research communications 2 (9), 987-1004, 2022 | 2 | 2022 |
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma PYF Zeng, SD Prokopec, SY Lai, N Pinto, MA Chan-Seng-Yue, ... Cell Reports 43 (3), 2024 | 1 | 2024 |
A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV− patients undergoing chemoradiation for oropharyngeal … F Laxague, PYF Zeng, D Zabihi, N Fnais, M Alshahrani, K Fung, ... Head & Neck 46 (3), 503-512, 2024 | 1 | 2024 |
The role of TIM3 and PD1 blockades in head and neck cancer M Shaikh, A Karimi, P Zeng, H Pan, J Barrett, A Nichols Cancer Research 84 (6_Supplement), 1377-1377, 2024 | | 2024 |
Understanding and overcoming innate and acquired resistance to type I and II RAF inhibitors in anaplastic thyroid cancer using translational functional genomics P Zeng, J Meens, J Barrett, MJ Cecchini, SB Ryan, N Pan, A Karimi, ... Cancer Research 84 (6_Supplement), 3580-3580, 2024 | | 2024 |